- Home
- INBK vs FENC Comparison
INBK vs FENC Comparison
Compare INBK & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBK
- FENC
- Stock Information
- Founded
- INBK 1999
- FENC 1996
- Country
- INBK United States
- FENC United States
- Employees
- INBK N/A
- FENC N/A
- Industry
- INBK Major Banks
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- INBK Finance
- FENC Health Care
- Exchange
- INBK Nasdaq
- FENC Nasdaq
- Market Cap
- INBK 196.2M
- FENC 229.8M
- IPO Year
- INBK N/A
- FENC 2001
- Fundamental
- Price
- INBK $23.32
- FENC $7.76
- Analyst Decision
- INBK Buy
- FENC Strong Buy
- Analyst Count
- INBK 4
- FENC 2
- Target Price
- INBK $34.50
- FENC $13.00
- AVG Volume (30 Days)
- INBK 37.3K
- FENC 87.6K
- Earning Date
- INBK 07-23-2025
- FENC 08-12-2025
- Dividend Yield
- INBK 1.03%
- FENC N/A
- EPS Growth
- INBK 27.37
- FENC N/A
- EPS
- INBK 2.40
- FENC N/A
- Revenue
- INBK $114,609,000.00
- FENC $30,912,000.00
- Revenue This Year
- INBK $5.36
- FENC $0.85
- Revenue Next Year
- INBK $17.09
- FENC $55.16
- P/E Ratio
- INBK $9.72
- FENC N/A
- Revenue Growth
- INBK 20.13
- FENC N/A
- 52 Week Low
- INBK $19.54
- FENC $3.96
- 52 Week High
- INBK $43.27
- FENC $8.72
- Technical
- Relative Strength Index (RSI)
- INBK 46.70
- FENC 51.69
- Support Level
- INBK $22.46
- FENC $7.53
- Resistance Level
- INBK $24.67
- FENC $8.19
- Average True Range (ATR)
- INBK 0.67
- FENC 0.47
- MACD
- INBK -0.05
- FENC -0.12
- Stochastic Oscillator
- INBK 38.91
- FENC 19.67
About INBK First Internet Bancorp
First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking or treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.